Competitive Technologies, Inc. to Present at Asia Conference on Technology Transfer

February 8, 2006

Fairfield, CT (February 8, 2006) - Competitive Technologies, Inc. (AMEX: CTT) today announced that it had been invited to participate in the First Asia Conference on Technology Transfer to be held in Seoul, Korea from March 15 (Wednesday) to March 17 (Friday), 2006. The conference is hosted by the Korea Technology Transfer Center, with whom Competitive Technologies has a very strong relationship. The conference has attracted over 500 participants and 60 speakers from more than 15 countries.

Dr. Mike Kiley, CTT's Executive Vice President and Chief Technology Officer, will give a presentation on CTT's success-based business models using examples of recent technology transfers from leading universities to commercial companies. Mr. Aris Despo, CTT's Senior Vice President, Life Sciences will give a presentation on CTT's very active homocysteine assay and life sciences licensing programs that have generated more than $50 million for its university clients during the last several years. Both of these programs also have generated significant royalty income for CTT.

Dr. D. J. Freed, CTT's President and Chief Executive Officer stated "we are honored to be invited to participate in this very prestigious event. Asia has long been the manufacturing epicenter of the globe and is now shifting their economic paradigm to technology-based innovation. This is an ideal arena for technology transfer and commercializing intellectual property, and Competitive Technologies looks forward to its participation, and to sharing our knowledge with our Asian partners".

About Competitive Technologies

Competitive Technologies, established in 1968, is a full service technology transfer and licensing provider focused on the technology needs of its customers and transforming those requirements into commercially viable solutions. CTT is a global leader in identifying, developing and commercializing innovative technologies in life and physical sciences, electronics, and nanotechnologies developed by universities, companies and inventors. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders.

Statements about our future expectations, including development and regulatory plans, and all other statements in this press release, other than historical facts, are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. If and when used herein, the words "may," "will," "should," "anticipate," "believe," "intend," "plan," "expect," "estimate," "approximate," and similar expressions, as they relate to us or our business or management, are intended to identify such forward-looking statements. These statements involve risks and uncertainties related to market acceptance of and competition for our licensed technologies, growth strategies, operating performance, industry trends, and other risks and uncertainties inherent in our business, including those set forth in Item 7 under the caption "Risk Factors," in our most recent Annual Report on Form 10-K for the year ended July 31, 2005, filed with the Securities and Exchange Commission ("SEC") on October 13, 2005, and other factors that may be described in our other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

Investor and Public Relations:
Johnnie D. Johnson
IR Services, LLC
Tel: 860.434.2465
Email: This email address is protected, Javascript must be enabled to view it